跳至主要内容
临床试验/CTRI/2018/06/014356
CTRI/2018/06/014356已完成1 期

Viral infections post renal transplantation: a pilot study to compare low dose vs standard dose valganciclovir prophylactic strategies for cytomegalovirus in renal transplant recipients

Postgraduate Institute of Medical Education and research0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients undergoing renal transplant during period of January 2018 to December 2018 with
  • 1)>= 16 years of age
  • 2)Adequate hematological and renal function(defined as a creatinine
  • 3)clearance >10 mL/min by day 10 posttransplant)
  • 4)CMV Donor/Recipient serostatus D+/R+, D+/Râ?? and D-/R+

排除标准

  • 1.)Patients refusing consent.
  • 2.)Significant gastrointestinal disease that could affect drug absorption.
  • 3.)suspected CMV disease at enrolment.
  • 4.)HIV, hepatitis B or hepatitis C
  • 5.)use of anti-CMV therapy within 30 days prior to study
  • 6.)multiple organ transplantation
  • 7.)allergies or previous adverse reactions to ganciclovir or valganciclovir
  • 8.)severe uncontrolled diarrhea or evidence of malabsorption
  • 9.)serious psychiatric or medical disorder
  • 10.)male with a pregnant partner.
  • 11.)liver function tests >3 times the upper level of normal (ULN).

研究者

相似试验